As Zhang et al. reported that CTT can inhibit the proliferation and migration of lung cancer cells, which was attributed to the IGF-1R-mediated phosphoinositide 3-kinase/AKT pathway 36. The gene discussed is AKT1; the disease is lung carcinoma.